Objective: This study aimed to describe and to analyze early severe digestive complications (ESDC) after lung transplantation (LT) in our center. Methods: A retrospective study included 351 patients, who underwent LT without cardiopulmonary bypass (CPB) at our center between March 1988 and December 2009. There were 86 double LTs and 265 single LTs. ESDCs were defined as complications (1) occurring during the first 30 days after transplantation or during initial hospitalization if longer; (2) involving the gastrointestinal tract; and (3) jeopardizing survival or requiring invasive therapeutic procedure. Patients' characteristics, associated risk factors, and influence of ESDC on early outcome have been analyzed. Results: During the first 30 days after LT or initial hospitalization if longer, 26 ESDCs occurred in 26 patients (rate 7.4%, sex ratio M/F 66%, mean age 56 AE 6 years). This included 10 acute cholecystitis (38%), four angiocholitis (15%), three perforated gastroduodenal ulcers (11%), three digestive perforations (11%), two intestinal occlusions (8%), two mesenteric ischemia (8%), and two acute pancreatitis (8%). ESDC occurred after a mean postoperative follow-up of 14 days (5-46), required emergency surgical treatment in 20 cases (77%), significantly prolonged the mean duration of hospitalization (96 days with ESDC vs 55 days without ESDC, p < 0.0001), and was responsible for death in five cases (19%). Surgical treatment included cholecystectomy (n = 11), bowel resection (n = 3), ulcer surgery (n = 2), subtotal colectomy (n = 2), Hartmann procedure (n = 1), and open coelioscopy (n = 1). Age and bilateral LTwere found to be significant risk factors for ESDC in both uni-and multivariate analyses. Conclusion: ESDC occurred in 7.4% of patients after LTwithout CPB, and was responsible for longer in-hospital stay. Relevant risk factors included older age and bilateral LT, interfering with current debate regarding recipients' selection and procedure's choice. #
Introduction
Lung transplantation (LT) is the only therapeutic option that can restore lung function in patients with end-stage pulmonary disease. According to the Registry of the International Society for Heart and Lung Transplantation (ISHLT) [1] , the 2708 procedures reported in 2007 were the highest of any year. Concomitantly, long-term survival has progressively increased, to reach overall 5-and 10-year survival rates of 52% and 29%, respectively.
Current limits of LT include graft shortage, early postoperative complications, and late bronchiolitis obliterans syndrome (BOS). Among postoperative complications, digestive involvement is associated with high morbidity and mortality [2] [3] [4] . Therefore, we sought to determine the frequency, risk factors, and prognosis of early, severe digestive complications (ESDCs) after LT.
Patients and methods

Overall population
Every patient, who underwent LT at Bichat-Beaujon Hospital Group between March 1988 and December 2009, was prospectively included in an electronic database. A total of 351 transplantations were performed during this period. The standard immunosuppression regimen was based on the association of tacrolimus, corticosteroids, and azathioprine. All patients received an antacid treatment based on a proton pump inhibitor. therapeutic procedure. Out of the 351 patients, who underwent LT without cardiopulmonary bypass (CPB), 26 patients (7.4%) fulfilled these criteria and accounted for the study group. The 325 remaining patients (92.6%) accounted for the control group.
Methods
All patients were followed with quarterly outpatient clinics. No patient was lost to follow-up. Management of ESDC was analyzed with mortality as primary end point. For abdominal procedures, indications, morbidity, mortality, and related risk factors were examined. In-hospital mortality from ESDC was calculated from the time of diagnosis of the complication. The following variables were identified as possible pre-transplant risk factors of post-transplant ESDC: age, sex, body mass index (BMI), diagnosis, type of LT (single (SLT) or bilateral (BLT)), and pulmonary function (partial pressure of carbon dioxide in the blood (PaO 2 ), partial pressure of carbon dioxide in the blood (PaCO 2 ) , forced expiratory volume in 1 s (FEV1), total lung capacity (TLC), and systolic pulmonary artery pressure (sPAP)). Inhaled corticosteroids, oral corticosteroids, or a combination of both, were given to all patients, and were therefore excluded from ESDC risk factors' analysis. Overall survival was calculated from the time of transplantation to the time of the death.
Statistical analysis
Normally distributed continuous variables were expressed as means AE standard deviation, and compared with unpaired t-tests. Non-normal variables were expressed as median AE interquartile range (IQR) and compared using MannWhitney U tests. Categorical data were expressed as counts and proportions, and compared with Fisher's exact tests. Survival was depicted with Kaplan-Meier estimate, and compared with the log-rank test. A multivariable logistic regression model was used to assess the relationship between variables measured before LT and the occurrence of an ESCD. We used purposeful selection of covariates to select the multivariate models. This is a manual method completely controlled by the data analyst. The first step was the inclusion of all variables significant at the 25% level on bivariate analysis, as well as all variables known or specifically hypothesized to be clinically important. The second step was to remove one by one variables that did not significantly contribute to the multivariate model on the basis of the p value of the Wald test (threshold of 0.05). All tests were two-sided and a p-value <0.05 was considered significant. All statistical analyses were performed with the SPSS (Statistical Package for Social Sciences) software (SPSS Inc., Chicago, IL, USA).
Results
Overall population
Demographics, diagnosis, and baseline characteristics of patients, who underwent LT without CBP during the study period, are summarized in Table 1 . Values are reported as n (%), mean (SD), or median [IQR] . IPF, idiopathic pulmonary fibrosis; COPD, chronic obstructive pulmonary disease; BO, bronchiolitis obliterans; BD, bronchiolitis dilatation; LCDD, light chains deposition disease; FEV1: forced expiratory volume in 1 s; BMI, body mass index; sPAP, systolic pulmonary artery pressure; SLT, single lung transplantation.
Study group
Among the 26 patients with ESDC, 16 were males and 10 were females (sex ratio M/F 1.6). The mean age was 56 AE 6.5 years. Preoperative explorations found a mean FEV1 of 607 AE 315 ml, a mean PaO 2 of 60 AE 12 mmHg, and a mean PAP of 40 AE 9 mmHg. SLT and BLT have been performed in 17 (65.3%) and nine (34.7%) patients, respectively (Table 1 ).
ESDC
The median time (interquartile range, IQR) between lung transplantation and ESDC was 14 days (8; 22) . Severe digestive complications included acute cholecystitis (n = 10, 38%), angiocholitis (n = 4, 15%), gastroduodenal ulcers (n = 3, 11%), digestive perforations (n = 3, 11%), intestinal occlusions (n = 2, 8%), mesenteric ischemia (n = 2, 8%), and acute pancreatitis (n = 2, 8%) ( Table 2 ).
Treatment
An emergency surgical treatment was necessary for 20 patients (5.7% of the overall population, 77% of patients with ESDC). Surgical treatments were: cholecystectomy (n = 11), bowel resection (n = 3), ulcer surgery (n = 2), subtotal colectomy (n = 2), Hartmann procedure (n = 1), and open coelioscopy (n = 1). The mean time from LT to the abdominal surgery was 14 AE 10 days (range 5-46). Six patients underwent endoscopic treatment (1.7% of the overall population, 23% of patients with ESDC), including endoscopic retrograde cholangiography and gastroduodenal fibroscopy.
Outcome
In the study group, the overall post-transplant 90-day mortality was 30.7% (n = 8), with digestive complications being directly responsible for the death of 19% of the patients with ESDC (n = 5). Causes of death are detailed in Table 3 . When comparing the study group with the control group, ESDCs were found to significantly prolong the duration of both intensive care unit (ICU) (median (IQR): 44 (24; 63) vs 20 (14; 33) days, p < 0.001) and hospital stays (median (IQR): 77 (32; 121) vs 45 (32; 72) days, p = 0.003), but were not significantly associated with any increase in 90-day mortality (30.7% vs 21.8%, p = 0.421) or overall survival ( p = 0.431) (Fig. 1 ).
Risk factors
In univariate analysis, age, FEV1, TLC, and pre-transplant diagnosis were associated with ESCD occurrence, whereas in multivariate analysis, only age and BLT were associated with ESDC occurrence (Table 4 ). There was no difference between right single-lung transplantation (R-SLT) and left single-lung transplantation (L-SLT) regarding ESDC.
Discussion
In this study, ESDCs occurred with a frequency of 7.4%, significantly lengthened the ICU stay, and are associated with a direct mortality of 19%, making ESDC frequent, associated with high morbidity, and responsible for substantial mortality after LT.
In the English literature, the rate of gastrointestinal complications after LT relies on the definition, from 3.2% among 375 patients when including only patients undergoing emergency abdominal surgery after lung or heart-lung transplantations [5] to 43% among 208 patients when including any post-transplant diagnosis related to the gastrointestinal tract [4] (Table 5) . In this study, ESDCs have been defined as complications involving the gastrointestinal tract and fulfilling three additional conditions. The complication should (1) occur during the first 30 days after transplantation or during initial hospitalization if longer; (2) jeopardize survival or require invasive therapeutic procedure; and (3) concern patients transplanted without CPB. First, this definition has been established to exclude late complications, which are more likely to be related to colitis [4, [6] [7] [8] , cholestasis, severe gastroesophageal reflux disease, and neoplasic disorders, including colon cancer and post-transplantation lymphoproliferative disorder [4, [9] [10] [11] , therefore requiring a different management. Second, this definition has been established to exclude digestive complications that neither require invasive procedure nor jeopardize survival, which have been reported to be frequent. Defining gastrointestinal complications as any diagnosis related to the gastrointestinal tract [4] or requiring a general surgery consultation [11] , previous studies have reported a high frequency (43-47%, respectively) and a wide range of diagnosis, making clear conclusions difficult to draw. Focusing on major procedures and their management is also expected to have the greatest impact on the prognosis of lung transplant recipients [12] . Third, patients who underwent LT Table 5 . Systematic review of the literature, including studies including more than 100 patients after lung transplantation, and published within the last 20 years. with CPB have been excluded, as only a small number of patient required CPB in our experience, and CPB appears to be a confusion factor associated with both digestive complications and higher mortality by itself [13, 14] . In the particular setting of LT, the use of CPB is associated with a longer period of postoperative mechanical ventilation, more pulmonary edema, more blood transfusion requirement, and an increase in postoperative mortality at 48 h and 1 month [15] . Thus, although restrictive, this definition of ESDCs distinguishes a homogeneous group of patients, allowing further analysis. ESDC is associated with high mortality [4, 5, 11, 12] , and has been reported to be a significant risk factor for post-transplant mortality [5] . This severity is explained by the underlying disease, frequent co-morbidities, and specific conditions of graft recipients. Patients who undergo LT are usually fragile, with a life expectancy of <2 years in the absence of transplantation [1] . Their baseline risk factors for digestive complications depend on their primary diagnosis. Non-deficient emphysema patients with past smoking habits are exposed to atherosclerotic bowel ischemia [16] . Idiopathic pulmonary fibrosis patients with prolonged corticotherapy are exposed to pancreatitis, gastrointestinal hemorrhage, and colonic perforations [7, 17] . Cystic fibrosis patients are exposed to gastroparesis and small bowel obstruction [18] . Regardless of the underlying pulmonary disease, ESDCs are mostly related to the cholecyst in our study because of the frequency of wellknown risk factors, including hypoperfusion, blood transfusion, positive pressure ventilation, and opioid medication. Furthermore, the diagnosis is often difficult in this context of immunosuppression, as it can mask significant intra-peritoneal pathology [7] . Delays in diagnosis and mortality have been shown to increase as steroid dose increase [19] . Therefore, a high index of suspicion and urgent aggressive diagnostic investigation of even vague abdominal symptoms are critical [20] . Patients should be beneficiated from physical examination with abdominal palpation once a day, biological examination with inflammation markers twice a week, and emergency abdominal computed tomography (CT) scan in case of abnormality of one of these. This systematic attitude may lead to an earlier diagnosis of ESDC and possibly a better outcome. Risk factors of digestive complications after LT have been little studied. The role of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has been outlined in one study [4] , but most of the other studies of digestive complications after LT are scattered and risk factors analysis have not been performed. In this study, age and BLT have been found to be significant risk factors of ESDC, but retransplantation has not, interfering with contemporary debate regarding recipients' selection and procedure's choice [21, 22] . In the absence of reference study, comparison can be performed with close situations, that is, heart transplantation, implantation of mechanical circulatory support, and lung volume reduction surgery (LVRS). After heart [23] and other solid organ transplantations [7] , diverticulitis and colon perforation are less frequent than after LT, probably due to the depth of immunosuppression required for the last. Another possible explanation is that the aggressive diuresis required to reverse reperfusion edema ultimately leads to constipation and exacerbation of underlying diverticular disease [7] . After LVRS, digestive complications are as frequent as after LT, outlying the role of chronic hypoxia on gastrointestinal tissue oxygenation and postoperative complications [24] . Finally, mechanical circulatory support therapy is mostly associated with abdominal wall complication, Clostridium difficile infection, and gastrointestinal bleeding, suggesting a weak role of circulatory failure in post-transplantation ESDC [25] . In our study, the increased risk of ESDC after double lung transplantation (DLT) as compared with SLT could be explained by the predominating role of hypoxia. Indeed, DLT is associated with longer graft ischemic time, longer procedure time, decreased blood oxygenation during single-lung ventilation on the graft side, and increased risk of primary graft failure. Therefore, DLT is associated with higher risk of per-and postoperative respiratory failure, which can contribute to ESDC, as suggested by LVRS experience.
Our study is exposed to several biases, including retrospective methodology, monocentric setting, pre-transplant diagnosis unbalance, historical modifications in the management of LT (i.e., donor and organ procurement, conservation solutions, and immunosuppressive regimen), and small number of patients. However, this study is the largest in the literature to date. Its results outline the frequency and mortality of ESDC, urge an aggressive management of abdominal symptoms in lung transplant patients, and constituted a plea for prospective multicentric databases collecting the outcome of lung transplant patients.
Conclusion
ESDCs are common in LT, and are associated with high morbidity, increasing ICU and hospital stay, and mortality. Relevant risk factors included older age and BLT, interfering with current debate regarding recipients' selection and procedure's choice. All together, these data suggest that SLT should be preferred to BLT in older patients with additional risk factors of digestive complications (past medical history of severe gastrointestinal disease, corticosteroid treatment, diabetes mellitus, etc.).
